Related Experiment Video
Updated: Oct 13, 2025

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
Published on: July 24, 2021
Multidrug-Resistant Infections in the Developing World
1Department of Pediatrics, Division of Pediatric Infectious Diseases and Global Health, UCSF Benioff Children's Hospital, Oakland, 747 52nd Street, Oakland, CA 94609, USA.
Antimicrobial resistance is a growing global threat, especially in low- and middle-income countries. Effective surveillance and reduced antimicrobial overuse are crucial to combatting this challenge and preserving drug effectiveness.
Area of Science:
- Global Health
- Infectious Diseases
- Pharmacology
Background:
- Antimicrobials are critical for treating infectious diseases worldwide.
- Increasing antimicrobial resistance (AMR) threatens global health.
- Low- and middle-income countries bear a disproportionately high burden of AMR.
Purpose of the Study:
- To highlight the growing threat of antimicrobial resistance.
- To emphasize the disproportionate burden of AMR in LMICs.
- To advocate for antimicrobial stewardship strategies.
Main Methods:
- Review of global antimicrobial resistance trends.
- Analysis of factors contributing to AMR.
- Discussion of antimicrobial stewardship interventions.
Main Results:
- Global increase in antimicrobial resistance documented.
- Significant burden of AMR identified in low- and middle-income countries.
- Lack of effective surveillance and overuse of antimicrobials identified as key drivers.
Conclusions:
- Antimicrobial resistance poses a significant global health risk.
- Targeted interventions are needed, particularly in LMICs.
- Antimicrobial stewardship, including surveillance and reduced overuse, is essential to combat AMR.
More Related Videos
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
07:50Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
Published on: October 25, 2024
Related Concept Videos
Development of Antibiotic Resistance
Antibiotic Selection
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Treatment Resistant Cancers